• $1,413.00
    Market Cap
  • 0.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
N/A
N/A
0
N/A
0
N/A
Cost of Revenue
0
N/A
0
N/A
0
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
7,453
+853.07%
782
+22.38%
639
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
0
N/A
Total Operating Expenses
646,472
+87.04%
345,624
-36.64%
545,470
N/A
Operating Profit
-646,472
+87.04%
-345,624
-36.64%
-545,470
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-964,536
+508.09%
-158,618
-61.44%
-411,312
N/A
Interest Income and Expense and Net
-964,536
+508.09%
-158,618
-61.44%
-411,312
N/A
Total Nonoperating Income and Expense
964,536
+508.09%
158,618
-61.44%
411,312
N/A
Income before Taxes
-1.4M
+123.77%
-630,324
-43.64%
-1.1M
N/A
Income Taxes
0
N/A
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.4M
+123.77%
-630,324
-40.87%
-1.1M
N/A
Net Income from Continuing Operations Applicable to Common
-1.4M
+123.77%
-630,324
-43.64%
-1.1M
N/A
Basic EPS and Net Income
0.00
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
0.00
N/A
N/A
N/A
0.00
N/A
Basic Weighted Average Shares
903.6M
+55.40%
581.5M
+4.81%
554.8M
N/A
Diluted Weighted Average Shares
903.6M
+55.40%
581.5M
+4.81%
554.8M
N/A
Balance Sheet
Cash and Cash Equivalents
210,257
+1,858.61%
10,735
N/A
0
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
210,257
+1,858.61%
10,735
N/A
0
N/A
Total Current Assets
210,257
+1,858.61%
10,735
N/A
0
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
0
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
0
N/A
Total Assets
8.7M
+81,067.44%
10,735
N/A
0
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
6.2M
+3,505.79%
171,531
-20.28%
215,160
N/A
Total Current Liabilities
6.7M
+568.51%
998,156
-12.68%
1.1M
N/A
Total Long-Term Debt
72,700
-55.56%
163,609
-10.12%
182,023
N/A
Total Long-Term Liabilities
242,001
-47.58%
461,626
N/A
0
N/A
Total Liabilities
6.7M
+568.51%
998,156
-12.68%
1.1M
N/A
Retained Earnings
-13.8M
+11.42%
-12.4M
+5.38%
-11.7M
N/A
Total Stockholders Equity
2.0M
+306.66%
-987,421
-9.32%
-1.1M
N/A
Total Shares Outstanding
1.4B
+100.37%
698.1M
+28.92%
541.5M
N/A
Cash Flow
Cash from Operating Activities
182,765
+234.62%
-135,765
-4.41%
-142,022
N/A
Capital Expenditures
N/A
N/A
75,000
N/A
0
N/A
Cash from Investing Activities
-9.2M
N/A
N/A
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.2M
+6,179.98%
146,500
+286.01%
37,952
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-32.34%
-99.72%
-11,743.34%
+30,884.42%
-37.90%
N/A
Return on Equity
-267.86%
-541.17%
60.72%
-79.44%
295.29%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.03
+191.67%
0.01
N/A
0.00
N/A
Cash Ratio
0.03
+191.67%
0.01
N/A
0.00
N/A
Debt-to-Equity Ratio
3.07
+1,003.54%
-0.34
-6.96%
-0.36
N/A
Debt-to-Assets Ratio
0.72
-97.70%
31.22
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow